Page last updated: 2024-12-10

11,12-dihydroxyeicosatrienoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 11,12-Dihydroxyeicosatrienoic acid (DiHETrE): A Key Player in Inflammation and Beyond

**11,12-Dihydroxyeicosatrienoic acid (DiHETrE)** is a lipid mediator formed from the omega-3 fatty acid **eicosapentaenoic acid (EPA)**. It's a **hydroxy-eicosatrienoic acid (HETrE)**, meaning it's a derivative of EPA with hydroxyl groups attached to carbons 11 and 12.

**Why is DiHETrE important for research?**

* **Inflammation:** DiHETrE is a potent **anti-inflammatory** agent. It acts by inhibiting the production of pro-inflammatory mediators like TNF-α and IL-1β, while promoting the release of anti-inflammatory cytokines like IL-10.
* **Cardiovascular Health:** Studies suggest DiHETrE might play a role in **reducing cardiovascular risk** by inhibiting platelet aggregation and reducing blood pressure.
* **Neuroprotection:** DiHETrE has shown **neuroprotective effects** in animal models of stroke and Alzheimer's disease.
* **Cancer:** DiHETrE has demonstrated **anticancer properties** in some studies, inhibiting tumor growth and promoting apoptosis.

**DiHETrE's Role in Research:**

* **Understanding Inflammation:** DiHETrE provides a crucial model for investigating the role of EPA-derived mediators in inflammation.
* **Developing New Therapies:** The anti-inflammatory, cardiovascular, and neuroprotective properties of DiHETrE make it a potential target for developing new drugs for a variety of diseases.
* **Unraveling the Complexities of Lipid Signaling:** DiHETrE's involvement in multiple biological processes highlights the complexity of lipid signaling pathways and their impact on human health.

**Current Research:**

Researchers are currently investigating the specific mechanisms by which DiHETrE exerts its effects, as well as its potential therapeutic applications in various diseases.

**Important Note:** DiHETrE is a product of EPA, which is an omega-3 fatty acid found in fatty fish, fish oil supplements, and some plant-based foods. While DiHETrE is a promising research target, it's important to consult with a healthcare professional before making any changes to your diet or supplementation.

(5Z,8Z,14Z)-11,12-dihydroxyicosatrienoic acid : A DHET obtained by formal dihydroxylation across the 11,12-double bond of arachidonic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5283146
CHEBI ID63969
SCHEMBL ID2508731
MeSH IDM0365236

Synonyms (24)

Synonym
LMFA03050008
(+/-)11,12-dihetre
11,12-dihydroxy-5z,8z,14z-eicosatrienoic acid
11,12-dhet
(5z,8z,14z)-11,12-dihydroxyeicosa-5,8,14-trienoic acid
(5z,8z,14z)-11,12-dihydroxyicosa-5,8,14-trienoic acid
11,12-dihetre
(5z,8z,14z)-11,12-dihydroxyicosatrienoic acid
11,12-dihydroxyeicosatrienoic acid
CHEBI:63969
192461-95-3
SCHEMBL2508731
11,12-dihydroxyeicosatrienoate
11,12-dihydroxy-5z,8z,14z-eicosatrienoate
(+/-)-11,12-dihydroxy-5z,8z,14z,17z-eicosatetraenoate
12-dihydroxyicosa-5,8,14-trienoate
(5z,8z,14z)-11,12-dihydroxyeicosa-5,8,14-trienoate
12-dihydroxyicosa-5,8,14-trienoic acid
11,12-dihydroxyicosa-5,8,14-trienoic acid
DTXSID701009862
Q27104911
11,12-dhet-[d11]
CS-0059604
HY-113111
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
DHETAn icosanoid obtained by formal dihydroxylation across one of the double bonds of arachidonic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (46)

PathwayProteinsCompounds
Arachidonic Acid Metabolism2966
Leukotriene C4 Synthesis Deficiency2966
Piroxicam Action Pathway2967
Acetylsalicylic Acid Action Pathway2967
Etodolac Action Pathway2967
Ketoprofen Action Pathway2967
Ibuprofen Action Pathway5076
Rofecoxib Action Pathway2967
Diclofenac Action Pathway2967
Sulindac Action Pathway2967
Celecoxib Action Pathway3573
Ketorolac Action Pathway2967
Suprofen Action Pathway2967
Bromfenac Action Pathway2967
Indomethacin Action Pathway3067
Mefenamic Acid Action Pathway2967
Oxaprozin Action Pathway2967
Nabumetone Action Pathway2967
Naproxen Action Pathway2967
Diflunisal Action Pathway2967
Meloxicam Action Pathway2967
Valdecoxib Action Pathway2967
Antipyrine Action Pathway2967
Antrafenine Action Pathway2967
Carprofen Action Pathway2967
Etoricoxib Action Pathway2967
Fenoprofen Action Pathway2967
Flurbiprofen Action Pathway2967
Magnesium Salicylate Action Pathway2967
Lumiracoxib Action Pathway2967
Lornoxicam Action Pathway2967
Phenylbutazone Action Pathway2967
Nepafenac Action Pathway2967
Trisalicylate-Choline Action Pathway2967
Tolmetin Action Pathway2967
Tiaprofenic Acid Action Pathway2967
Tenoxicam Action Pathway2967
Salsalate Action Pathway2967
Salicylate-Sodium Action Pathway2967
Salicylic Acid Action Pathway2967
Acetaminophen Action Pathway2967
Eicosanoid metabolism via cytochrome P450 monooxygenases pathway113
Arachidonic acid (AA, ARA) oxylipin metabolism076
Eicosanoid metabolism via cytochrome P450 monooxygenases213
Arachidonate epoxygenase / epoxide hydrolase09
Arachidonic acid metabolism via CYP (Cytochromoe P450) pathway014

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (50.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.48

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.48 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.48)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (10.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]